NS Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

Home » News » Company News » Castle Biosciences Announces Commercial Launch of DecisionDx DiffDx-Melanoma » medic-563425_640

Castle Biosciences Announces Commercial Launch of DecisionDx DiffDx-Melanoma

NS Medical Devices is using cookies

Castle Biosciences Announces Commercial Launch of DecisionDx DiffDx-Melanoma. (Credit: Darko Stojanovic from Pixabay.)

Related Article

Six medical devices that help patients manage diabetes

RECOMMENDED COMPANIES

MOST READ

Six medical devices that help patients manage diabetes

The bluetooth-powered neural implant that could speed up research into depression and addiction

A closer look at six of Italy’s biggest medical device companies

Can a Fitbit help manage the symptoms of type-two diabetes?

How do Covid-19 antibody tests work and are they effective?

Recommended Whitepaper